Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
McKinsey
Farmers Insurance
Harvard Business School
Covington
UBS
Baxter
Novartis
Express Scripts
Deloitte

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,551,616

« Back to Dashboard

Summary for Patent: 6,551,616
Title: Extended release formulations of erythromycin derivatives
Abstract:Disclosed is a pharmaceutical composition for extended release of an erythromycin derivative in the gastrointestinal environment. The composition comprises an erythromycin derivative and a pharmaceutically acceptable polymer so that, when ingested orally, the composition induces statistically significantly lower C.sub.max in the plasma than an immediate release composition of the erythromycin derivative while maintaining bioavailability and minimum concentration substantially equivalent to that of the immediate release composition of the erythromycin derivative upon multiple dosing. The compositions of the invention have an improved taste profile and reduced gastrointestinal side effects as compared to those for the immediate release composition.
Inventor(s): Notario; Gerard F. (Chicago, IL), Palmer; Robert N. (Gurnee, IL), Hom; Richard C. (Wilmette, IL), Zhang; Jie (Basking Ridge, NJ), Devcich; Karen J. (Grayslake, IL), Semla; Susan J. (Evanston, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:09/416,916
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,551,616

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,551,616

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1494911 ➤ Try a Free Trial
Canada 2358395 ➤ Try a Free Trial
Canada 2387621 ➤ Try a Free Trial
Canada 2465698 ➤ Try a Free Trial
Czech Republic 9903471 ➤ Try a Free Trial
China 100408044 ➤ Try a Free Trial
Colombia 4940403 ➤ Try a Free Trial
Czech Republic 294333 ➤ Try a Free Trial
Germany 69819481 ➤ Try a Free Trial
Denmark 0973527 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Johnson and Johnson
Teva
Medtronic
Moodys
Covington
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot